← Search & browse all drugs
CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE › Corticosteroids
betamethasone
C05AA05
Forms & Strengths
- Cream 0.1%
- Ointment 0.1%
- Lotion 0.1%
- Tablets 0.5mg, 0.75mg
- Injection 4mg/mL
Adult Dosing
- Apply topically 1-2 times daily
- Oral: 0.5-5mg daily
- IM injection: 4-8mg as a single dose
Pediatric Dosing
- Topical: Apply 1-2 times daily, adjust according to response
- Oral: 0.02-0.1mg/kg/day in 2-4 divided doses
Indications
- Skin conditions: eczema, psoriasis, dermatitis
- Allergic reactions: anaphylaxis, asthma
- Rheumatic disorders: rheumatoid arthritis, bursitis
- Endocrine disorders: congenital adrenal hyperplasia
Mechanism of Action
- GLUCOCORTICOID RECEPTOR AGONIST
- Induces anti-inflammatory, immunosuppressive, and metabolic effects
Contraindications
- Hypersensitivity to betamethasone
- Intramuscular injection in idiopathic thrombocytopenic purpura
- Live or attenuated vaccines in patients on immunosuppressive doses
Adverse Reactions
- Hypertension, insomnia, mood changes, Cushing's syndrome
- Glaucoma, cataracts, increased intraocular pressure
- Peptic ulcers, pancreatitis, weight gain, hirsutism
Drug Interactions
- Warfarin: monitor INR, adjust warfarin dose
- Aspirin and nonsteroidal anti-inflammatory drugs: increase risk of gastrointestinal ulcers
- Phenobarbital, phenytoin, and rifampicin: decrease betamethasone efficacy
Curated Content: Needs Vetting Before Put to Clinical Use